Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mammary gland but fails to prevent cell loss in the mammary glands of mice expressing iGFBP-5 as a mammary transgene

D.J. Flint, M. Boutinaud, C.B.A. Whitelaw, G.J. Allan, A.F. Kolb

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Insulin-like growth factor-binding protein 5 (IGFBP-5) mediates involution of the mammary gland. The decrease in DNA content and mammary gland weight which accompanies involution was inhibited by prolactin (PRL) in wild-type but not transgenic mice expressing IGFBP-5. Phospho-STAT5 protein levels were significantly lower in IGFBP-5 transgenic mice during lactation suggesting that IGFBP-5 antagonises PRL signalling in the mammary epithelium. In contrast, phospho-STAT3 levels increased during involution to a similar extent in both wild-type and transgenic mice and were unaffected by PRL. PRL inhibited gene expression of matrix metalloproteinases (MMPs) 3 and 12 but not tissue plasminogen activator or plasmin in wild-type and transgenic animals. The effects of PRL on MMPs appear to be indirect since PRL failed to inhibit MMP-3, -7 or -12 expression in HC-11 cells or in a co-transfection including an activated PRL receptor, STAT5 and a MMP-3-luciferase reporter gene. PRL is a potent inhibitor, both of cell death, an effect which is suppressed by IGFBP-5, and of MMP expression, which is independent of the actions of IGFBP-5.

Original languageEnglish
Pages (from-to)435-448
Number of pages14
JournalJournal of Molecular Endocrinology
Volume36
DOIs
Publication statusPublished - 2006

Fingerprint

Insulin-Like Growth Factor Binding Protein 5
Human Mammary Glands
Matrix Metalloproteinases
Transgenes
Prolactin
Breast
Matrix Metalloproteinase 3
Transgenic Mice
Matrix Metalloproteinase 12
STAT5 Transcription Factor
Matrix Metalloproteinase 7
Prolactin Receptors
Genetically Modified Animals
Wild Animals
Fibrinolysin
Tissue Plasminogen Activator
Luciferases
Reporter Genes
Lactation
Transfection

Keywords

  • Insulin-like growth factor-binding protein 5
  • IGFBP-5
  • prolactin
  • matrix metalloproteinases
  • MMPs
  • PRL

Cite this

@article{17720cb26076442ba0cf3ee6675caabc,
title = "Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mammary gland but fails to prevent cell loss in the mammary glands of mice expressing iGFBP-5 as a mammary transgene",
abstract = "Insulin-like growth factor-binding protein 5 (IGFBP-5) mediates involution of the mammary gland. The decrease in DNA content and mammary gland weight which accompanies involution was inhibited by prolactin (PRL) in wild-type but not transgenic mice expressing IGFBP-5. Phospho-STAT5 protein levels were significantly lower in IGFBP-5 transgenic mice during lactation suggesting that IGFBP-5 antagonises PRL signalling in the mammary epithelium. In contrast, phospho-STAT3 levels increased during involution to a similar extent in both wild-type and transgenic mice and were unaffected by PRL. PRL inhibited gene expression of matrix metalloproteinases (MMPs) 3 and 12 but not tissue plasminogen activator or plasmin in wild-type and transgenic animals. The effects of PRL on MMPs appear to be indirect since PRL failed to inhibit MMP-3, -7 or -12 expression in HC-11 cells or in a co-transfection including an activated PRL receptor, STAT5 and a MMP-3-luciferase reporter gene. PRL is a potent inhibitor, both of cell death, an effect which is suppressed by IGFBP-5, and of MMP expression, which is independent of the actions of IGFBP-5.",
keywords = "Insulin-like growth factor-binding protein 5 , IGFBP-5, prolactin, matrix metalloproteinases, MMPs, PRL",
author = "D.J. Flint and M. Boutinaud and C.B.A. Whitelaw and G.J. Allan and A.F. Kolb",
year = "2006",
doi = "10.1677/jme.1.01873",
language = "English",
volume = "36",
pages = "435--448",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",

}

TY - JOUR

T1 - Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mammary gland but fails to prevent cell loss in the mammary glands of mice expressing iGFBP-5 as a mammary transgene

AU - Flint, D.J.

AU - Boutinaud, M.

AU - Whitelaw, C.B.A.

AU - Allan, G.J.

AU - Kolb, A.F.

PY - 2006

Y1 - 2006

N2 - Insulin-like growth factor-binding protein 5 (IGFBP-5) mediates involution of the mammary gland. The decrease in DNA content and mammary gland weight which accompanies involution was inhibited by prolactin (PRL) in wild-type but not transgenic mice expressing IGFBP-5. Phospho-STAT5 protein levels were significantly lower in IGFBP-5 transgenic mice during lactation suggesting that IGFBP-5 antagonises PRL signalling in the mammary epithelium. In contrast, phospho-STAT3 levels increased during involution to a similar extent in both wild-type and transgenic mice and were unaffected by PRL. PRL inhibited gene expression of matrix metalloproteinases (MMPs) 3 and 12 but not tissue plasminogen activator or plasmin in wild-type and transgenic animals. The effects of PRL on MMPs appear to be indirect since PRL failed to inhibit MMP-3, -7 or -12 expression in HC-11 cells or in a co-transfection including an activated PRL receptor, STAT5 and a MMP-3-luciferase reporter gene. PRL is a potent inhibitor, both of cell death, an effect which is suppressed by IGFBP-5, and of MMP expression, which is independent of the actions of IGFBP-5.

AB - Insulin-like growth factor-binding protein 5 (IGFBP-5) mediates involution of the mammary gland. The decrease in DNA content and mammary gland weight which accompanies involution was inhibited by prolactin (PRL) in wild-type but not transgenic mice expressing IGFBP-5. Phospho-STAT5 protein levels were significantly lower in IGFBP-5 transgenic mice during lactation suggesting that IGFBP-5 antagonises PRL signalling in the mammary epithelium. In contrast, phospho-STAT3 levels increased during involution to a similar extent in both wild-type and transgenic mice and were unaffected by PRL. PRL inhibited gene expression of matrix metalloproteinases (MMPs) 3 and 12 but not tissue plasminogen activator or plasmin in wild-type and transgenic animals. The effects of PRL on MMPs appear to be indirect since PRL failed to inhibit MMP-3, -7 or -12 expression in HC-11 cells or in a co-transfection including an activated PRL receptor, STAT5 and a MMP-3-luciferase reporter gene. PRL is a potent inhibitor, both of cell death, an effect which is suppressed by IGFBP-5, and of MMP expression, which is independent of the actions of IGFBP-5.

KW - Insulin-like growth factor-binding protein 5

KW - IGFBP-5

KW - prolactin

KW - matrix metalloproteinases

KW - MMPs

KW - PRL

UR - http://dx.doi.org/10.1677/jme.1.01873

U2 - 10.1677/jme.1.01873

DO - 10.1677/jme.1.01873

M3 - Article

VL - 36

SP - 435

EP - 448

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

ER -